Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 8;7(2):29.
doi: 10.3390/geriatrics7020029.

Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis

Affiliations

Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis

Nazia Rashid et al. Geriatrics (Basel). .

Abstract

This retrospective cohort study described changes in all-cause healthcare resource utilization (HCRU) and associated costs in dementia patients newly diagnosed with psychosis. Dementia and incident psychosis were identified using diagnostic and pharmacy claims using a Medicare 20% random sample dataset. All-cause HCRU and unweighted and weighted (by person-years of follow-up) HCRU-associated costs were evaluated in the year prior to and the 4 years following diagnosis of psychosis. In 49,509 dementia patients with psychosis, physician visits per patient per year increased from a mean of 26.7 (standard deviation (SD) 20.0) prior to psychosis to 38.4 (SD 41.9) post-psychosis diagnosis. The number of inpatient stay claims increased from 1.0 (SD 1.4) to 1.7 (SD 5.8). Mean unweighted costs for inpatient stays and home healthcare/hospice during 2008-2016 were USD 9989 and USD 3279 prior to a diagnosis of psychosis but increased to USD 25,982 and USD 9901 (weighted: USD 11,779 and USD 6709), respectively, in the year after a psychosis diagnosis. This pattern of a sharp increase in mean costs was also observed in costs adjusted to 2015 USD, and in both unweighted and weighted total and psychosis-related costs. These results indicate the importance of identifying newly diagnosed psychosis in dementia patients as well as the pressing need for management strategies and treatments that can reduce HCRU and costs.

Keywords: Medicare; delusions; dementia; economic burden; hallucinations; psychosis.

PubMed Disclaimer

Conflict of interest statement

James B. Wetmore is employed by the Chronic Disease Research Group, which received research funding from Acadia Pharmaceuticals Inc., and has served on ad hoc advisory boards for the BMS-Pfizer alliance. Victor Abler and Nazia Rashid are salaried employees of Acadia Pharmaceuticals Inc. Muna Irfan has nothing to disclose.

Figures

Figure 1
Figure 1
Annualized unweighted all-cause costs per patient per year by type of Medicare setting adjusted to 2015 USD. LTC and Medicare costs may not sum to total row costs due to rounding. Abbreviations: DME = durable medical equipment; LTC = long-term care; SNF = skilled nursing facility.
Figure 2
Figure 2
Annualized unweighted all-cause costs per patient per year overall in Medicare and LTC in 2015 USD. Abbreviation: LTC = long-term care.
Figure 3
Figure 3
Annualized unweighted psychosis-related costs per patient per year by type of Medicare Setting in 2015 USD. LTC and Medicare costs may not sum to total row costs due to rounding. Abbreviations: DME = durable medical equipment; LTC = long-term care; SNF = skilled nursing facility.

Similar articles

References

    1. Deb A., Thornton J.D., Sambamoorthi U., Innes K. Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States. Expert Rev. Pharmacoecon. Outcomes Res. 2017;17:189–202. doi: 10.1080/14737167.2017.1313118. - DOI - PMC - PubMed
    1. Maust D.T., Kales H.C., McCammon R.J., Blow F.C., Leggett A., Langa K.M. Distress Associated with Dementia-Related Psychosis and Agitation in Relation to Healthcare Utilization and Costs. Am. J. Geriatr. Psychiatry. 2017;25:1074–1082. doi: 10.1016/j.jagp.2017.02.025. - DOI - PMC - PubMed
    1. Ku L.E., Chang S.M., Pai M.C., Hsieh H.M. Predictors of caregiver burden and care costs for older persons with dementia in Taiwan. Int. Psychogeriatr. 2019;31:885–894. doi: 10.1017/S1041610218001382. - DOI - PubMed
    1. Aigbogun M.S., Stellhorn R., Hartry A., Baker R.A., Fillit H. Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: A claims database analysis. BMC Neurol. 2019;19:33. doi: 10.1186/s12883-019-1260-3. - DOI - PMC - PubMed
    1. Murman D.L., Chen Q., Powell M.C., Kuo S.B., Bradley C.J., Colenda C.C. The incremental direct costs associated with behavioral symptoms in AD. Neurology. 2002;59:1721–1729. doi: 10.1212/01.WNL.0000036904.73393.E4. - DOI - PubMed

LinkOut - more resources